Previous Close | 0.0300 |
Open | 0.0300 |
Bid | 0.0000 |
Ask | 0.0200 |
Strike | 125.00 |
Expire Date | 2024-10-18 |
Day's Range | 0.0300 - 0.0300 |
Contract Range | N/A |
Volume | |
Open Interest | 3.1k |
(Bloomberg) -- Johnson & Johnson didn’t wrongly manipulate bankruptcy rules when it filed an insolvency case in Texas and not its home state of New Jersey, a federal judge ruled, increasing the odds the consumer health giant can settle claims its baby powder gave women cancer.Most Read from BloombergThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsSan Francisco to Shut 9% of Public Schools Amid Budget WoesChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilUrban Hea
We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we will look at where Johnson & Johnson (NYSE:JNJ) ranks among the list of stocks that mutual funds are buying according to Goldman Sachs. As the fourth quarter of 2024 starts, the market […]
NEW YORK (Reuters) -A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a federal bankruptcy court in Texas, a judge ruled on Thursday, allowing the company to avoid a venue that shot down its two previous efforts. U.S. Bankruptcy Judge Christopher Lopez at a hearing in Houston rejected arguments raised by the U.S. Department of Justice's Office of the U.S. Trustee, its bankruptcy watchdog, and attorneys representing some of the women suing the company who are opposed to the settlement. They had argued that the case should be sent to a U.S. bankruptcy court in New Jersey, which oversaw and dismissed two previous bankruptcies meant to resolve the same talc lawsuits.